Immediate Impact
3 by Nobel laureates 1 from Science/Nature 53 standout
Citing Papers
Tumor biomarkers for diagnosis, prognosis and targeted therapy
2024 Standout
A systematic review and meta-analysis of nonrelapse mortality after CAR T cell therapy
2024 Standout
Works of Julie Chang being referenced
A Three-Arm Randomized Phase II Study of Bendamustine/Rituximab with Bortezomib Induction or Lenalidomide Continuation in Untreated Follicular Lymphoma: ECOG-ACRIN E2408
2020
Phase I Study of Dovitinib (TKI258), an Oral FGFR, VEGFR, and PDGFR Inhibitor, in Advanced or Metastatic Renal Cell Carcinoma
2013
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Julie Chang | 360 | 249 | 366 | 42 | 776 | |
| E. Heidemann | 425 | 214 | 502 | 42 | 779 | |
| Jens Krugmann | 420 | 225 | 391 | 38 | 833 | |
| Roberta Burnelli | 373 | 192 | 220 | 39 | 810 | |
| Jun Miyauchi | 291 | 113 | 255 | 40 | 783 | |
| Geoffrey Chong | 294 | 172 | 374 | 56 | 740 | |
| Bernard Lemieux | 334 | 234 | 250 | 36 | 779 | |
| Nili Peylan‐Ramu | 156 | 208 | 239 | 24 | 937 | |
| Alessia Bari | 540 | 172 | 441 | 53 | 884 | |
| C Bayle | 317 | 184 | 253 | 38 | 729 | |
| Annette Zimpfer | 380 | 166 | 357 | 59 | 916 |
All Works
Login with ORCID to disown or claim papers
Loading papers...